OBJECTIVE: The study predicts long-term cervical cancer related population health and
economic effects of introducing the HPV-vaccination for 12-year-old girls (and boys) in …

Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …

Introduction Persistent infections with human papillomavirus (HPV) are a necessary cause of
cervical cancer and are responsible for important morbidity in men and women. Since 2007 …

Objectives: the study aims to estimate the clinical-impact and cost-effectiveness value of
adding human papillomavirus 16/18 vaccination against cervical cancer among women …

Objectives: The cost-effectiveness of adding a human papillomavirus (HPV) vaccination
program in 12-year-old females to the recommended cervical cancer screening in Belgium …

We evaluated the cost‐effectiveness of HPV16/18 vaccination for girls aged 12 years in The
Netherlands in addition to cervical cancer screening. For this purpose, we developed a …

Background: There is a large difference in the prevalence of cervical cancer between
European countries. Between European Union countries, cervical cancer is the most …

Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus
virus (HPV) vaccination in France, using a generally applicable succinct cohort model …

Background: The objective of the present study is to evaluate the cost-effectiveness of
human papillomavirus (HPV) vaccination alongside cervical cancer screening programme in …

Background Estonia has high cervical cancer incidence and low screening coverage. We
modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV …